Back to Journals » ClinicoEconomics and Outcomes Research » Volume 6

Economic burden of asthma in Abu Dhabi: a retrospective study

Authors Alzaabi A, Alseiari M, Mahboub B

Received 6 June 2014

Accepted for publication 15 July 2014

Published 17 October 2014 Volume 2014:6 Pages 445—450


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Ashraf Alzaabi,1 Mohammed Alseiari,2 Bassam Mahboub3

1Respiratory Medicine Division, Zayed Military Hospital, Abu Dhabi, United Arab Emirates; 2General Secretariat of Executive Council, Abu Dhabi, United Arab Emirates; 3University of Sharjah, Rashid Hospital, Sharjah, United Arab Emirates

Abstract: This study evaluates the direct costs of treating asthma in Abu Dhabi in the United Arab Emirates. Data was compiled for 2011 from health insurance claims covering all medical interventions or treatments coded as asthma. Costs were calculated from a health care perspective. The total direct cost of treating 139,092 asthma patients was estimated to be United Arab Emirates Dirhams (AED) 105 million (US$29 million), corresponding to around AED 750 per patient per annum. The total cost is principally generated by outpatient visits (>AED 85 million; 81% of the total cost). Ten point four percent of patients had made an emergency room visit. The cost per visit seems to be higher during hospital admissions (AED 7,123) compared to outpatient visits and emergency room visits. The direct cost of asthma medications was around AED 33 million (31% of the total cost). The economic burden of asthma in Abu Dhabi is high and the number of emergency visits suggests that the disease is not optimally controlled.

Keywords: asthma, cost, Abu Dhabi, UAE, Middle East

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]